The global industry for CAR T-cell therapy in treating Non-Hodgkin's lymphoma is undergoing rapid growth. This trend is fueled by several factors, including rising prevalence of Non-Hodgkin's lymphoma, progresses in CAR T-cell therapy technology, and increasing implementation by healthcare practitioners. The market is divided based on factors such … Read More